A mitochondria-targeted iridium(iii)-based photoacid generator induces dual-mode photodynamic damage within cancer cells-Reference-Cited by-同舟云学术

A mitochondria-targeted iridium(iii)-based photoacid generator induces dual-mode photodynamic damage within cancer cells

Published:2019 Issue:70 Volume:55 Page:10472-10475
ISSN:1359-7345
Container-title:Chemical Communications
language:en
Short-container-title:Chem. Commun.

Author:

He Liang¹²³⁴⁵^ORCID,Zhang Ming-Fang⁶⁷⁸⁹⁵,Pan Zheng-Yin⁶⁷⁸⁹⁵,Wang Kang-Nan⁶⁷⁸⁹⁵,Zhao Zi-Jian⁶⁷⁸⁹⁵,Li Yi¹⁰¹¹¹²¹³¹⁴^ORCID,Mao Zong-Wan¹²³⁴⁵^ORCID

Affiliation:

1. Department of Applied Chemistry

2. College of Materials and Energy

3. South China Agricultural University

4. Guangzhou 510642

5. China

6. MOE Key Laboratory of Bioinorganic and Synthetic Chemistry

7. School of Chemistry

8. Sun Yat-sen University

9. Guangzhou 510275

10. Key Laboratory of Theoretical Organic Chemistry and Function Molecule

11. Ministry of Education

12. School of Chemistry and Chemical Engineering

13. Hunan University of Science and Technology

14. Xiangtan 411201

Abstract

An Ir(iii)-based photoacid generator was developed as a dual-mode photodynamic therapy agent to kill cancer cells under hypoxic conditions.

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

National Basic Research Program of China

Ministry of Education of the People's Republic of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Metals and Alloys,Surfaces, Coatings and Films,General Chemistry,Ceramics and Composites,Electronic, Optical and Magnetic Materials,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2019/CC/C9CC04871E

Reference32 articles.

1. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI

2. Recent advances in functional nanomaterials for light–triggered cancer therapy

3. Recent advances in near-infrared emitting lanthanide-doped nanoconstructs: Mechanism, design and application for bioimaging

4. Exploiting tumour hypoxia in cancer treatment

5. Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial signaling pathways and their role in cancer drug resistance;Cellular Signalling;2024-10

2. Photoinduction of Ferroptosis and cGAS-STING Activation by a H₂S-Responsive Iridium(III) Complex for Cancer-Specific Therapy;Journal of Medicinal Chemistry;2024-09-09

3. Porphyrin Derivative with Binary Properties of Photodynamic Therapy and Water‐Dependent Reversible Photoacidity Therapy for Treating Hypoxic Tumor;Advanced Healthcare Materials;2024-01-14

4. Evaluation of multi-target iridium(iii)-based metallodrugs in combating antimicrobial resistance and infections caused by Staphylococcus aureus;RSC Advances;2024

5. Lysosome-targeted cyclometalated Ir(iii) complexes as photosensitizers/photoredox catalysts for cancer therapy;Dalton Transactions;2024